title: FDA regulation of off-label drug promotion under attack.
authors: Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 1620 Tremont St, Ste 3030, Boston, MA 02120, USA. akesselheim@partners.org
authors: Aaron S
authors: AS
authors: Kesselheim
authors: Michelle M
authors: MM
authors: Mello
authors: Jerry
authors: J
authors: Avorn
mesh_terms: D000329:Advertising; D004345:Drug Industry / Q000191:economics / Q000941:ethics; D004501:Education, Medical / Q000191:economics / Q000941:ethics; D006801:Humans; D007880:Legislation, Drug; D056687:Off-Label Use / Q000941:ethics / Q000331:legislation & jurisprudence*; D013060:Speech; D014342:Truth Disclosure; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence*